Second, mannose-modified stearic acid-grafted chitosan micelles (MChSA) overcome antigen uptake limitations by DCs, enabling targeted delivery to tumor-draining lymph nodes (TDLN) and inducing robust CD4+/CD8+ T-cell responses with tumor growth inhibition [181]. The gene discussed is CD8A; the disease is neoplasm.